Ortin Global Ltd

NSE: ORTINGLOBE · BSE: 539287 · Pharmaceuticals & Biotechnology · 18 announcements

Share price: ₹15.10
Market cap: ₹12.28 Cr
Revenue (annual): ₹0.10 Cr
Net profit (annual): ₹-0.74 Cr
P/E (TTM): -13.6×Sector 47.4×
Promoter holding: 1.23%+0.00% QoQ
FII holding: 1.80%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Open Offer 3 Financial Results 3 Debt & Borrowing 2 Board Meeting Date 2 Management Change 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

30 Apr 2026 19:47 IST NSE

Debt & Borrowing

Ortin Global Debt & Borrowing

Ortin Global Limited informed exchanges that it does not fall under the 'Large Corporate' category for FY 2025-26 as per SEBI debt-raising frameworks. Consequently, mandatory borrowing requirements through debt securities are not applicable to the company for this period.

Read the filing ↗

30 Apr 2026 19:24 IST BSE

Debt & Borrowing

Ortin Global Debt & Borrowing: ₹1.05 Cr

Ortin Global Ltd clarified it does not qualify as a 'Large Corporate' under SEBI norms for FY 2026-27. The company reported outstanding borrowings of ₹1.05 Crore, falling below the ₹1,000 Crore threshold. This disclosure is a routine regulatory requirement regarding debt-raising frameworks.

Value: ₹1.05 Cr

Read the filing ↗